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Abstract
Background: It has been suggested that trans fatty acids (TFAs) play an important role in cardiovascular
diseases. We investigated the association between plasma TFAs and the dietary inflammatory index (DII) ™ in
US adults.
Methods: National Health and Nutrition Examination Survey (NHANES) participants with data on plasma TFAs
measured from 1999 to 2010 were included. Energy-adjusted-DII ™ (E-DII ™) expressed per 1000 kcal was calculated
from 24-h dietary recalls. All statistical analyses accounted for the survey design and sample weights.
Results: Of the 5446 eligible participants, 46.8% (n = 2550) were men. The mean age of the population was 47.1 years
overall, 47.8 years for men and 46.5 years for women (p = 0.09). After adjustment for C-reactive protein, body-mass-index,
smoking, race, age, education, and marital status in linear regressions, trans 9-hexadecenoic acid [β coefficient 0.068 (95%
CI: 0.032 to 0.188)], trans 11-octadecenoic acid [β coefficient 0.143 (95% CI: 0.155 to 0.310)], trans 9-octadecenoic acid [β
coefficient 0.122 (95% CI: 0.120 to 0.277)], trans 9, and trans 12-octadienoic acid [β coefficient 0.103 (95% CI: 0.090 to 0.
247)] were positively associated with the DII (all p < 0.001).
Conclusion: The association of plasma TFAs with a marker of dietary inflammation suggests an underlying mechanism in
the initiation and progression of cardiovascular diseases.
Keywords: Trans fatty acids, Dietary inflammatory index, National Health and nutrition examination survey

Background
Trans-fatty acids (TFAs) are unsaturated fatty acids with
at least one unsaturated, non-conjugated double bond in
the trans (rather than the typical cis) configuration.
Because humans do not synthesize trans-fatty acids,
levels of these fatty acid isomers in serum depend on
dietary intake. TFAs occur naturally in fat from ruminant animal meat, milk, and dairy fat and artificially in
industrially hardened vegetable oils [1]. Dietary exposure
to partially hydrogenated vegetable oils occurs through
consumption of margarine and industrially processed
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foods such as cakes, candies, cookies, chocolate, mayonnaise, potato chips, French fries and other deep-fat fried
foods, and fast food more generally [2].
Increased dietary intake of TFAs is linked with incident cardiovascular disease (CVD), and Type 2 diabetes
mellitus (T2DM) [3–6]. A recent observational study [7]
and a short-term randomized trial [8] have indicated
that TFAs intake increases systemic inflammation in
generally healthy individuals. Because systemic inflammation is an independent risk factor for future CVD [9],
these findings suggest a potential mechanism whereby
TFAs may affect cardiovascular health. Recommendations from the American Heart Association have led 13
local governments to implement a TFA ban [10] and the
Food and Drug Administration to require the TFAs
content to be listed on the nutrition facts panel of foods
and dietary supplements [10].
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Pro- or anti-inflammatory properties have been
described for a number of foods and nutrients, and
extensive literature research on these food items and
nutrients has led to the development of the Dietary
Inflammatory Index (DII)™ [11]. The goal of this
index was to use different food parameters, categorized as pro- or anti-inflammatory, in order to calculate the inflammatory property of a person’s total diet
[11, 12]. Previously, the DII was associated with a range
of outcomes including markers of systemic inflammation,
CVD, bone mineral density, telomere length, and overall
mortality [13–15]. A relationship between the DII and
levels of serum inflammatory markers has been found in
multiple cohorts [11, 13, 16, 17]. However, no study has
evaluated the association between plasma TFA concentration and DII scores. Therefore, our aim was to investigate
the association between plasma TFA as an indicator of inflammation and the DII in US adults. We hypothesized
that concentration of TFAs in serum will be higher with
increasing DII scores.

using liquid-liquid extraction and derivatized with pentafluorobenzylbromide (PFB-Br). The derivatized fatty
acids are separated by capillary gas chromatography and
detected by mass spectrometry using negative chemical
ionization. The fatty acids are identified based on their
chromatographic retention time and on the specific
mass to charge ratio of the ion formed in the ion source.
Retention times are compared against those obtained
with known standards. Quantitation is performed with
standard solution using stable isotope-labelled fatty acids
as internal standards. To calculate trans fatty acids as
percent of total fatty acids, 29 fatty acids are determined
with this measurement procedure. These fatty acids
cover over 95% of all fatty acids reported in plasma. This
method determines the following four trans fatty acids:
trans-9-hexadecenoic acid (palmitelaidic acid, C16:1n7 t), trans-9-octadecenoic acid (elaidic acid, C18:1n-9 t),
trans-11-octadecenoic acid (vaccenic acid, C18:1n-7 t-),
trans-9, trans-12-octadecadienoic acid (linolelaidic acid,
C18:2n-6 t, 9 t) [22].

Methods

Diet and dietary inflammatory index

Population

The development and validation of the DII have been
described in detail elsewhere [12]. In short, nearly 2000
research articles, published between 1950 and 2010,
examining the relationship between components of diet
and pro-inflammatory cytokines (i.e., IL-1β, IL-6,
tumour necrosis factor [TNF]-α, and C-reactive protein
(CRP)) and anti-inflammatory cytokines (IL-4 and IL-10)
were reviewed. This search revealed that 45 different
food parameters (mostly micro, macro nutrients and
flavanoids plus some individual food items) had a sufficiently robust literature to allow for scoring. Articles
showing a positive association between the food parameters and the pro-inflammatory cytokines or a negative
association with anti-inflammatory cytokines received a
value of +1. If the food parameters were associated with
reduced
pro-inflammatory
or
increased
antiinflammatory cytokines, the article received a value of
−1. Null values were set to 0. These scores were
weighted based on study design. For example, randomized control trials received the greatest weight and cell
culture the lowest weight. These scores and the weights
were used to create pro- and anti-inflammatory fractions
for each food parameter. The anti-inflammatory fraction
was subtracted from the pro-inflammatory fraction to
create the “article effect score” for each of the 45 food
parameters. Additionally, DII calculation is linked to a
regionally representative world database. The world
database contains standard means and deviations for the
45 food parameters from 11 populations around the
world (i.e., United States, United Kingdom, Bahrain,
Mexico, Australia, South Korea, Taiwan, India, New
Zealand, Japan, and Denmark) [12]. Dietary data in

The National Health and Nutrition Examination Surveys
(NHANES) are ongoing repeated cross sectional studies
performed by the US National Center for Health Statistics (NCHS) [18]. NHANES applies a multistage probability sampling strategy, that oversamples certain
subgroups of the U.S. population [19]. The NCHS Research Ethics Review Board approved the NHANES
protocol and consent was obtained from all participants.
Approximately 5000 subjects participate in NHANES
each year, and the data are stated in 2-year cycles accessible for public domain [20]. Data collection on demographic, dietary, and behavioral information occurs
through in-home administered questionnaires, though
anthropometric measurements and biomarker variables
are collected by trained subjects applying the mobile
exam clinics (MEC). The interview consists of questions
on socio-demographic characteristics (age, gender, education and race/Hispanic origin). More comprehensive
information on the NHANES protocol is accessible elsewhere [21]. This study was based on analysis of data
from the 1999 to 2010 NHANES cycles. Analyses were
limited to subjects aged 18 years and older.
Plasma trans fatty acids

This measurement procedure determines the total (free
and esterified) content of selected TFAs in plasma and
provides results in concentration units as well as percent
units (trans fatty acids as percent of total fatty acids).
The fatty acids in plasma are converted into free fatty
acids by subsequent acidic and alkaline hydrolysis. The
free fatty acids are extracted from the sample solution
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NHANES were collected using 24-h dietary recall interviews (24HR) conducted at the MEC [23]. The dietary
interviews were administered by trained staff and the
USDA’s Food Surveys Research Group was responsible
for the dietary data collection methodology, maintenance of the databases used to code and process the data,
and data review and processing [24]. 24HR-derived dietary information was used to calculate DII scores for all
subjects, as described in detail elsewhere [12]. Higher
(i.e., more positive) scores tend to indicate more proinflammatory diets and more negative values are more
anti-inflammatory [12]. To control for the effect of total
energy intake, the DII was calculated per 1000 cal of
food consumed, which requires using the energystandardized version of the world database.

Statistical analysis

We conducted the analyses according to the Center
for Diseases Control and Prevention guidelines for
analysis of complex NHANES data, accounting for
the masked variance and using the proposed weighting methodology [25–28]. We computed C-reactive
protein, body-mass-index, smoking, race, age, education, and marital status-adjusted plasma TFAs level
across quartiles of the DII by using analysis of covariance (ANCOVA) with Bonferroni correction. To determine any association between plasma TFAs and
DII, we used multivariable-adjusted linear regression
models adjusted for C-reactive protein, body-massindex, smoking, race, age, education, marital status.
All tests were two sided, and the level of significance
as set at p < 0.05. We have applied complex sample
analysis to deal with unequal probabilities of
selection, nonresponse bias, and oversampling.
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Results
Of the 11,973 eligible participants, 47.8% (n = 5725)
were men. The mean age was 47.1 years overall,
47.8 years in men and 46.5 years in women (p = 0.085).
In all, 40.6% (n = 4864) of the participants had
completed more than high school, 21.1% (n = 2522) had
completed high school, while 30.6% (n = 3672) had
completed less than high school. White (non-Hispanic)
represented 45.1% (n = 5405) of the participants, Blacks
18.6% (n = 2230) and Mexican-Americans 23.2%
(n = 2779). The distribution of marital status was 50.9%
(5659) for married, 9.5% (n = 1055) for widowed and
9.3% (n = 1035) for divorced. Means and standard
deviations for TFAs for subjects with information on
TFAs concentration were 1.55 ± 0.52 μmol/L for trans
9-hexadecenoic acid, 3.18 ± 0.61 μmol/L for trans 11octadecenoic acid, 2.96 ± 0.67 μmol/L for trans 9octadecenoic acid and 0.68 ± 0.21 μmol/L for trans 9,
trans 12-octadienoic acid, respectively. Mean BMI was
28.5 ± 6.6Kg/m2 overall, 28.0 ± 5.7 Kg/m2 in men and
29.0 ± 7.3 Kg/m2 in women (p = 0.012). DII score
ranged from −5.33 to 4.24 with a median of −0.01
(25th–75th percentiles: −1.40-1.20).
Adjusted mean Trans 9-hexadecenoic acid, trans 11octadecenoic acid, trans 9-octadecenoic acid, trans 9,
and trans 12-octadienoic acid significantly increased
across increasing quarters of the DII (p < 0.001, Table 1).
In C-reactive protein, body-mass-index, smoking, race,
age, education, and marital status adjusted linear regressions, Trans 9-hexadecenoic acid [β coefficient (β) 0.068
(95% CI: 0.032 to 0.188)], trans 11-octadecenoic acid [β
0.143 (95% CI: 0.155 to 0.310)], trans 9-octadecenoic
acid [β 0.122 (95% CI: 0.120 to 0.277)], and trans 9, trans
12-octadienoic acid [β 0.103 (95% CI: 0.090 to 0.247)]
were directly related to DII score (all p < 0.001).

Table 1 adjusted (C-reactive protein, body mass-index, smoking, race, age, education, marital status)mean of trans fatty acids across
the quarters of the DII
Variables
Min and Max of DII
crude

adjusted

P-value

Quarters of the dietary inflammatory index

trans 9-hexadecenoic acid

Quarter 1

Quarter 2

Quarter 3

Quarter 4

−5.33 to − 1.40

−1.40 to − 0.02

−0.02 to 1.20

1.20 to 4.24

1.57 ± 0.03

1.63 ± 0.02

1.64 ± 0.03

1.56 ± 0.02

0.095

trans 11-octadecenoic acid

3.10 ± 0.02

3.20 ± 0.02

3.29 ± 0.05

3.32 ± 0.07

<0.001

trans 9-octadecenoic acid

2.92 ± 0.04

2.95 ± 0.02

3.02 ± 0.05

3.12 ± 0.03

<0.001

trans 9, trans 12-octadienoic acid

0.65 ± 0.04

0.74 ± 0.02

0.76 ± 0.03

0.82 ± 0.02

<0.001

trans 9-hexadecenoic acid

1.37 ± 0.04

1.40 ± 0.04

1.44 ± 0.02

1.50 ± 0.04

<0.001

trans 11-octadecenoic acid

2.91 ± 0.03

2.96 ± 0.05

3.06 ± 0.04

3.32 ± 0.05

<0.001

trans 9-octadecenoic acid

2.80 ± 0.04

2.82 ± 0.02

2.87 ± 0.03

2.96 ± 0.04

<0.001

trans 9, trans 12-octadienoic acid

0.62 ± 0.04

0.69 ± 0.04

0.72 ± 0.03

0.80 ± 0.03

<0.001

Adjusted for C-reactive protein, body mass-index, smoking, race, age, education, marital status. Analysis of covariance applied. Value expressed as a mean SEM.DII,
dietary inflammatory index
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Discussion
In this population-based sample, we have evaluated the
association between plasma TFA and the DII. We found
a positive association between plasma TFA and DII
scores, which remained significant even after adjusting
for a range the potential confounding factors.
Evidence from both observational and experimental
studies indicates that TFAs are pro-inflammatory [5, 7,
29, 30], which is in line with our findings. The mechanisms underlying these effects are not well-established,
but may involve TFAs incorporation into endothelial
cell, monocyte/macrophage, or adipocyte cell membranes (affecting membrane signalling pathway relating
to inflammation) or ligand-dependent effects on
peroxisome-proliferator-activated receptor-g (PPAR-g)
or retinoid X receptor (RXR) pathways [5, 7]. Activation
of inflammatory responses and endothelial dysfunction
may represent important mediating pathways between
TFAs consumption and the risk of coronary heart
diseases, sudden death, and T2DM [29]. It has been reported that TFA treatment of human aortic endothelial
cell (HAEC) significantly increased the expression of
endothelial adhesion molecules, including intercellular
adhesion molecule-1 (CD54) and vitronectin receptor
(CD51/CD61) [31]. Incorporation of TFA into membranes increased HAEC adhesion to fibronectin- or
vitronectin-coated plates by 1.5- to 2-fold, respectively
[31]. Neutrophil and monocyte adhesion to HAEC
monolayers was nearly proportional to adhesion
molecule expression. TFA treatment also induced the release of monocyte chemoattractant protein-1 by nearly
threefold in non-stimulated HAEC [31]. TFA elevates inflammatory markers such as CRP, TNF alpha, and IL-6
[8, 32]. Mozaffarian et al. observed that TFA levels were
positively associated with interleukin (IL) 1ß, IL-1 receptor antagonist, IL-10, tumor necrosis factor (TNF) α,
TNF receptor 2, monocyte chemoattractant protein 1,
and brain natriuretic peptide [7].
Some of the deleterious actions of the TFAs such as
increasing insulin resistance have been attributed to its
pro-inflammatory action. A recent study in mice demonstrated increased insulin resistance and signs of local inflammation in adipose tissue, as well as induction of
cytokine gene expression after treatment with
trans10cis12-CLA [33]. Adipocytes exposed to CLA secreted more pro-inflammatory cytokines than controls,
and there was an increased macrophage infiltration in
adipose tissue treated with trans10cis12-CLA [33]. Another mechanism, as indicated by many studies in CLAfed mice, is down-regulation of PPAR-γ in adipose tissue
[33–35], resulting in subsequent peripheral insulin resistance in skeletal muscle. Data in mice also suggest
that CLA could promote a lipodystrophic state, with redistribution of fat stores, i.e. increased liver fat
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accumulation and decreased peripheral fat, also consistent with down-regulation of PPAR-g [35].
The effects of TFA consumption on cardiovascular
events have not been evaluated in randomized controlled
trials in humans. Such trials are unlikely to be performed, given the cost considerations, practicality, compliance and, perhaps most importantly, the ethical
limitations of randomizing individuals to an intervention
with strong evidence for significant harm. A prior metaanalysis of observational studies reported pooled relative
risk estimates for CHD of 1.22 (95% confidence interval
1.08 to 1.38) for highest level of total intake of TFAs;
1.30 (0.80 to 2.14) for intake of industrially produced
TFAs; and 0.93 (0.74 to 1.18) for intake of ruminant derived TFAs [36]. This suggests that industrially produced
TFAs might increase the risk of CHD, though this also
could reflect the low levels of ruminant derived TFAs
compared with the higher doses of industrially produced
TFAs typically consumed in studies and availability in
the food supply [37]. A meta-analysis by Souza et al., reported that a 2% increase in energy intake from TFAs
was associated with a 25% increased risk of CHD and
31% increase in CHD mortality [38]. Other metaanalyses also have reached the same conclusion [5, 39].
With regard to stroke, at least two prospective studies
assessed the association between TFAs and ischemic
stroke, and yielded inconsistent results [40, 41]. One
study in men showed no association with stroke [40];
the other, in women, showed a positive association in
those who did not take aspirin [41]. Furthermore, the association with TFAs was significant only for lacunar
stroke, with a trend for haemorrhagic stroke, but not for
stroke of cardioembolic origin. A nested case-control
study conducted within the Women’s Health Initiative
Observational Study with 10 year follow-up found no
association between serum TFAs 16:1, 18:1, or 18:2 and
ischemic stroke [42].
This study has several strengths. To our knowledge,
it is the largest study of the association of plasma
TFAs with the DII. The study is sufficiently powered
to test the targeted associations. Participants were a
random sample of the general population and therefore the results obtained from nationally representative samples can be extrapolated to the general
population. As the data collection was performed on
all days of the week throughout the year in NHANES,
the potential for selection bias is very low [43, 44].
The findings from our study have to be considered in
the context of some study limitations. The crosssectional nature does not allow inference about
causality; it is possible there is reverse causation,
whereas it is not a case for our results since increased plasma TFAs cannot cause someone to eat a
pro-inflammatory diet.
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Conclusions
Understanding the interplay between plasma TFA and
DII is a necessary and important step toward any application of the resulting knowledge for public health
policy and action. Our findings provide evidence on
the association between plasma TFAs with the DII.
The association of plasma TFAs and with a marker of
inflammation suggests an underlying mechanism of
harmful health effects.
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